Clinical Trial

Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

Name: Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis — clinical trial record (NCT06979271)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated May 18, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

The aim of this study is to observe the clinical efficacy and safety of telitacicept combined with tofacitinib in the treatment of D2TRA patients

Trial Details

NCT Number	NCT06979271
Lead Sponsor	Zhejiang Provincial People's Hospital
Conditions	Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Enrollment	20 participants
Start Date	2025-06-01
Primary Completion	2026-04-30 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-18